Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
Clinical trial NCT04092205 · COMPLETED
Trial details
- NCT number
- NCT04092205
- Sponsor
- EmeraMed
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2020-07-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.